Post-earnings recap
Reported
Mon, Aug 8, 2011
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
25%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Arrowhead Pharmaceuticals reported a loss of $0.03 per share, which was below expectations. The stock reacted negatively, dropping 3.92%. The lack of revenue information and guidance may contribute to investor uncertainty moving forward.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.03 | N/A | -50.00% |
| Revenue | — | N/A | — |
No transcript is on record for this earnings call, so the analysis is based solely on the numerical results reported.